/Investor DB

Cambridge Angels group — 2023 Investments

5 investments dated 2023 · listed companies and verified rows first · show all

Albothermalbotherm.cominJun 2023

Albotherm develops a heat-activated coating for adaptive glazing that changes transparency in response to temperature, validated in commercial greenhouse trials and in development for the built environment, energy, and mobility surfaces.

AgTechCleantechClimate TechDeep TechNew MaterialsBristol, GB

Siân Fussell(Co-founder & CTO)inMolly(Co-founder & CEO)

Co-investorsInnovate UKGreen Angel VenturesOxford Investment Opportunity Network (OION)Sustainable VenturesBristol Private Equity ClubEmpirical Ventures+1 more

Five Alarm Biofivealarmbio.comFeb 2023

Five Alarm Bio develops pharmaceutical compounds targeting a novel aging mechanism to prevent and treat age-related chronic diseases.

BiotechLongevity

William Bains(Founding scientist)in

Co-investorsO2h VenturesSyndicateRoom

Paragraf - companyparagraf.comin𝕏Apr 2023

Paragraf develops graphene-based electronic devices, including molecular sensors (electrolyte-gated field-effect transistors) for biosensing and chemical sensing, and Hall effect sensors for current, position, and magnetic field measurement at cryogenic temperatures.

Deep TechNew MaterialsSemiconductorsCambridgeshire, GB

Simon Thomas(Chief Executive Officer of the issuer.)in

Co-investorsAmadeus Capital PartnersBlack Opal VenturesEMV CapitalIn-Q-TelIQ CapitalMartlet Capital+5 more

Precision medicineconcr.coinSeed · Mar 2023 · $2M

Concr combines AI-driven computational methods with biological expertise to develop precision oncology tools that improve drug selection and delivery for cancer patients.

AI & Machine LearningBiotechMedical DevicesGlasgow, GB

Matthew Griffiths(Chief Technology Officer & Co-Founder)Uzma Asghar(Advisor, Medical Strategy & Co-Founder)Matt Foster(Non-Executive Director (Australia) & Co-Founder)

Co-investorsAvonmore DevelopmentsDebiopharm Innovation FundDeep Science VenturesOncology Ventures

Zero RISC Labszerorisc.comin𝕏Seed · Oct 2023 · $5M

ZeroRISC provides end-to-end security for open-source silicon, covering chip design-time IP, factory provisioning, and lifecycle/fleet management built on an open-source silicon root of trust.

CybersecurityHardwareSemiconductorsSomerville, US

Dominic Rizzo(Executive Officer, Director)inZakir Durumeric(Director)Gavin Ferris(Director)Robert Mullins(Director)Dom Rizzo(Founder)

Co-investorsAvonmore DevelopmentsFontinalis PartnersAmadeus Capital SA

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.